The 1989 Nobel Prize In Medicine: 20 Who Deserve It

Pity the Nobel committee now trying to make its selection for the next prize in physiology or medicine, soon to be announced. The committee has a very difficult task. The five-member group at the Karolinska Institute in Stockholm is sifting through dossiers on more than 100 candidates. The committee members are no doubt asking themselves, as they must ask themselves every year, “How are we to select from among this collection of outstanding, world-class researchers just one (or at mos

Written byDavid Pendlebury
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Pity the Nobel committee now trying to make its selection for the next prize in physiology or medicine, soon to be announced. The committee has a very difficult task.

The five-member group at the Karolinska Institute in Stockholm is sifting through dossiers on more than 100 candidates. The committee members are no doubt asking themselves, as they must ask themselves every year, “How are we to select from among this collection of outstanding, world-class researchers just one (or at most three) to honor with the Nobel Prize in Medicine?” All of the candidates have conducted exceptional research all are of the highest scientific caliber. Plainly, there are more scientists worthy of receiving the prize than there are Nobel Prizes to go around.

That circumstance leaves a great number of researchers “who are peers of prize winners in every sense except that of having the award,” Columbia University sociologist of science ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies